Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 9:13 AM ET | Feedback | Site Changes | Help
The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.
View All Commentary (ELN)
Recs
TMFBiologyFool (99.24) Submitted: 6/16/08 4:18 PM : Start Price: $26.49 ELN Score: -35.39
A bet on the phase 2 trial results of its Alzheimer's drug being disappointing even if its promising.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK